Cancer

T-Therapeutics appoints Dr David Hung as Chairman

T-Therapeutics appoints Dr David Hung as Chairman Industry veteran, founder of Medivation and serial entrepreneur joins T-Therapeutics to support development…

7 months ago

Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint

SHANGHAI, June 11, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading…

7 months ago

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

14-month data show treatment with setrusumab resulted in a large, sustained 67% reduction in annualized fracture rate and persistent median annualized fracture…

7 months ago

Alida Biosciences Announces Series A Funding and Early Access Launch of Innovative Products for Epitranscriptomic Research

SAN DIEGO, June 12, 2024 /PRNewswire/ -- Alida Biosciences (AlidaBio), an innovator in epigenomic research tools, proudly announces the successful completion…

7 months ago

MindBio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial

VANCOUVER, BC / ACCESSWIRE / June 12, 2024 / MindBio Therapeutics Corp. (CSE:MBIO)(Frankfurt:WF6), (the "Company" or "MindBio"), a leading biopharmaceutical…

7 months ago

San Diego-Based Shoreline Recovery Center Provides Addiction Awareness, Mental Health Resources Through Community Education

SAN DIEGO, CA / ACCESSWIRE / June 11, 2024 / For those afflicted by substance abuse and mental illness, it's…

7 months ago

“Self-Taught” AI Tool Helps to Diagnose and Predict Severity of Common Lung Cancer

NEW YORK, June 11, 2024 /PRNewswire/ -- A computer program based on data from nearly a half-million tissue images and…

7 months ago

Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations

Latest version includes a prebuilt pangenome capturing more genetic diversity, reducing ancestry bias, and improving accuracy SAN DIEGO, June 11,…

7 months ago

DeepScribe Collaborates with Texas Oncology to Provide AI Solution for Complex Patient Documentation

New technology will enhance patient experience at Texas Oncology locations by reducing administrative burden for clinicians SAN FRANCISCO, June 11,…

7 months ago

New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy

Avenda Health's study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and…

7 months ago